SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-245912
Filing Date
2019-09-16
Accepted
2019-09-16 17:17:43
Documents
22
Period of Report
2019-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d802733d8k.htm   iXBRL 8-K 47316
2 EX-4.1 d802733dex41.htm EX-4.1 592931
3 EX-10.1 d802733dex101.htm EX-10.1 205378
4 EX-99.1 d802733dex991.htm EX-99.1 14294
8 GRAPHIC g802733dsp74.jpg GRAPHIC 2783
9 GRAPHIC g802733dsp75.jpg GRAPHIC 3424
10 GRAPHIC g802733dsp76.jpg GRAPHIC 3392
11 GRAPHIC g802733dsp77.jpg GRAPHIC 3766
12 GRAPHIC g802733dsp79.jpg GRAPHIC 2323
13 GRAPHIC g802733dsp80.jpg GRAPHIC 4445
14 GRAPHIC g802733g0916221244810.jpg GRAPHIC 2579
  Complete submission text file 0001193125-19-245912.txt   1197325

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA apls-20190911.xsd EX-101.SCH 3067
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20190911_lab.xml EX-101.LAB 18139
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20190911_pre.xml EX-101.PRE 11406
22 EXTRACTED XBRL INSTANCE DOCUMENT d802733d8k_htm.xml XML 3333
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38276 | Film No.: 191095287
SIC: 2834 Pharmaceutical Preparations